Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-08 16:16:07 ET
Evolus, Inc. (EOLS) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST
Company Participants
Nareg Sagherian - Head of Global Investor Relations & Corporate Communications
David Moatazedi - President, CEO & Director
Rui Avelar - Chief Medical Officer and Head of Research & Development
Tatjana Mitchell - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript
Evolus Inc.
NASDAQ: EOLS
EOLS Trading
-2.42% G/L:
$5.24 Last:
197,327 Volume:
$5.30 Open:
EOLS Latest News
EOLS Stock Data
$288,448,039
43,258,131
1.1%
49
N/A
Pharmaceuticals
Healthcare
US
Newport Beach
